IMNM
Immunome, Inc.
NASDAQ · USHealthcareBiotechnology
$22.16-0.72%
Price as of Jul 20, 2026
IMNM valuation
Immunome, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 98.99x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.26x
- Price / sales
- 625.06x
- Price / cash flow
- -12.77x
Enterprise value
- Enterprise value
- $1.9B
- EV / sales
- 480.85x
- EV / EBITDA
- -8.71x
- EV / EBIT
- -8.08x
- Market cap
- $2.5B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.